Jan 13, 2025
Did you know that limiting genetic testing to
castration-resistant disease is subpar to testing at the
hormone-sensitive stage in prostate cancer?
Credit available for this activity expires: 01/09/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002043?ecd=bdc_podcast_libsyn_mscpedu